[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:g1-s-specific-cyclin-e1":3},{"name":4,"total":5,"recruiting":5,"trials":6},"G1\u002FS-Specific Cyclin-E1",14,[7,15,22,28,34,40,47,53,60,66,72,78,83,89],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05687136","Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors",[11],"Phase 1","RECRUITING","2026-08-26T02:17:30.145302Z","2026-07-05T05:32:16.811559Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT07023627","A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression",[19],"Phase 2","2026-08-26T02:18:54.586325Z","2026-05-05T02:43:29.352359Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT04855656","Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors",[11],"2026-08-26T02:19:19.975067Z","2026-05-05T02:43:28.817590Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":32,"content_modified":33},"NCT02523014","Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas",[19],"2026-08-26T02:16:38.897933Z","2026-05-05T02:43:27.482521Z",{"nct_id":35,"title":36,"phases":37,"status":12,"updated_at":38,"content_modified":39},"NCT02896335","Palbociclib and Pembrolizumab In Central Nervous System Metastases",[19],"2026-08-26T02:18:38.865010Z","2026-07-24T01:27:14.926741Z",{"nct_id":41,"title":42,"phases":43,"status":12,"updated_at":45,"content_modified":46},"NCT06726148","Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+\u002FHER2- Breast Cancer and in Patients With Other Advanced Solid Tumors",[44],"Phase 1\u002FPhase 2","2026-08-26T02:18:14.396999Z","2026-07-19T19:36:05.056471Z",{"nct_id":48,"title":49,"phases":50,"status":12,"updated_at":51,"content_modified":52},"NCT07029399","A Study With NKT5097 for Adults With Advanced\u002FMetastatic Solid Tumors",[11],"2026-08-26T02:15:53.461103Z","2026-06-16T05:54:07.931783Z",{"nct_id":54,"title":55,"phases":56,"status":12,"updated_at":58,"content_modified":59},"NCT07546500","A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression",[57],"Phase 3","2026-08-26T02:16:48.735701Z","2026-05-29T15:36:40.191734Z",{"nct_id":61,"title":62,"phases":63,"status":12,"updated_at":64,"content_modified":65},"NCT07214779","Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression",[57],"2026-08-26T02:19:08.084946Z","2026-05-05T02:43:28.882083Z",{"nct_id":67,"title":68,"phases":69,"status":12,"updated_at":70,"content_modified":71},"NCT06997029","A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors",[11],"2026-08-26T02:18:01.700186Z","2026-05-05T02:43:26.752915Z",{"nct_id":73,"title":74,"phases":75,"status":12,"updated_at":76,"content_modified":77},"NCT05128825","A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer",[19],"2026-08-26T02:16:05.813655Z","2026-05-05T02:43:26.726187Z",{"nct_id":79,"title":80,"phases":81,"status":12,"updated_at":70,"content_modified":82},"NCT05867251","Study of AVZO-021 in Patients With Advanced Solid Tumors",[44],"2026-05-05T02:43:29.354579Z",{"nct_id":84,"title":85,"phases":86,"status":12,"updated_at":87,"content_modified":88},"NCT05735080","Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer",[44],"2026-08-26T02:18:36.226508Z","2026-05-05T02:43:26.743725Z",{"nct_id":90,"title":91,"phases":92,"status":12,"updated_at":93,"content_modified":94},"NCT06586957","A Study With NKT3964 for Adults With Advanced\u002FMetastatic Solid Tumors",[11],"2026-08-26T02:15:23.202838Z","2026-04-29T02:57:57.069931Z"]